Inventor · disambiguated record
Paul Hallenbeck
Also filed as: HALLENBECK PAUL · HALLENBECK PAUL L
8 granted patents·19 pending applications·432 citations·filing 1995–2022
89Inventor score
Files withCELL GENESYS INC5GENETIC THERAPY INC4SENECA THERAPEUTICS INC4HALLENBECK PAUL L2NOVARTIS AG2
Top patents by PatentIndex Score
27 records- 0196US5998205AVectors for tissue-specific replicationGENETIC THERAPY INC·Filed 1995·Granted Dec 7, 1999·294 cites·20 claims
- 0286US8039606B2Seneca Valley virus based compositions and methods for treating diseaseNOVARTIS AG·Filed 2009·Granted Oct 18, 2011·6 cites·3 claims
- 0384US7109029B2Vector constructsCELL GENESYS INC·Filed 2002·Granted Sep 19, 2006·29 cites·27 claims
- 0484US6638762B1Tissue-vectors specific replication and gene expressionGENETIC THERAPY INC·Filed 1997·Granted Oct 28, 2003·58 cites·59 claims
- 0583US8753622B2Seneca valley virus based compositions and methods for treating diseaseHALLENBECK PAUL·Filed 2011·Granted Jun 17, 2014·5 cites·5 claims
- 0683US6551587B2Vectors for tissue-specific replicationGENETIC THERAPY INC·Filed 1998·Granted Apr 22, 2003·34 cites·87 claims
- 0780US7638318B2Seneca Valley virus based compositions and methods for treating diseaseNORVARTIS AG·Filed 2006·Granted Dec 29, 2009·6 cites·9 claims
- 0867US2008213884A1Vectors for tissue-specific replicationCELL GENESYS INC·Filed 2007·Application pending·0 cites
- 0967US2008076172A1Vectors for tissue-specific replicationCELL GENESYS INC·Filed 2007·Application pending·0 cites
- 1065US2006002897A1Vectors for tissue-specific replicationHALLENBECK PAUL L·Filed 2005·Application pending·0 cites
- 1164US2007086985A1Vectors for tissue-specific replicationCELL GENESYS INC·Filed 2006·Application pending·0 cites
- 1263US2008103109A1Vectors for tissue-specific replicationHALLENBECK PAUL L·Filed 2007·Application pending·0 cites
- 1361US2014348798A1Seneca valley virus based compositions and methods for treating diseaseNEOTROPIX INC·Filed 2014·Application pending·0 cites
- 1460US2003129175A1Vectors for tissue-specific replicationFiled 2002·Application pending·0 cites
- 1560US2003118570A1Vectors for tissue-specific replicationFiled 2002·Application pending·0 cites
- 1656US2004009588A1Vectors for tissue-specific replication and gene expressionGENETIC THERAPY INC·Filed 2003·Application pending·0 cites
- 1754US2003113296A1Vectors for tissue-specific replicationFiled 2002·Application pending·0 cites
- 1852US2024307470A1Armed seneca valley virus oncolytic therapy compositions and methods thereofSENECA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1951US2024100107A1Seneca valley virus combination therapy to treat a cancer refractory to a checkpoint inhibitorSENECA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2051US2009098599A1Adenovirus vectors, packaging cell lines, compositions, and methods for preparation and useNOVARTIS AG·Filed 2007·Application pending·0 cites
- 2148US2007275915A1Tmprss2 Regulatory Sequences and Uses ThereofCELL GENESYS INC·Filed 2004·Application pending·0 cites
- 2247US2007212675A1Flap Endonuclease (Fen1) Regulatory Sequences And Uses ThereofIRM LLC·Filed 2004·Application pending·0 cites
- 2344US12502414B2Second generation Seneca Valley virus oncolytic therapy: compositions and methods thereofSENECA THERAPEUTICS INC·Filed 2020·Granted Dec 23, 2025·0 cites·18 claims
- 2443US2022202884A1Compositions and methods of using seneca valley virus (svv) for treating cancerSENECA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2540US2002137213A1Adenovirus particles with mutagenized fiber proteinsFiled 2001·Application pending·0 cites
- 2639US2003104625A1Novel oncolytic adenoviral vectorsFiled 2002·Application pending·0 cites
- 2728US2002115202A1Adenoviral vectors including dna sequences encoding angiogenic inhibitorsFiled 1999·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →